Willingness to accept Doxycycline post-exposure prophylaxis for bacterial stis prevention among men who have sex with men in Southern China: a cross-sectional analysis
Doxycycline post-exposure prophylaxis (doxy-PEP) has the potential to decrease the incidence of sexually transmitted infections (STIs) among men who have sex with men (MSM). However, there is a limited literature on willingness to use doxy-PEP among Chinese MSM. This study aimed to examine the willi...
Saved in:
| Published in | BMC infectious diseases Vol. 25; no. 1; pp. 911 - 10 |
|---|---|
| Main Authors | , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
BioMed Central Ltd
11.07.2025
BioMed Central BMC |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Doxycycline post-exposure prophylaxis (doxy-PEP) has the potential to decrease the incidence of sexually transmitted infections (STIs) among men who have sex with men (MSM). However, there is a limited literature on willingness to use doxy-PEP among Chinese MSM. This study aimed to examine the willingness to use doxy-PEP and its associated factors among MSM in China.
In 2023, we conducted a cross-sectional study in four cities in Guangdong provinces in South China. Data were collected on social-demographic characteristics, sexual behaviors, and the willingness to use doxy-PEP. Multivariable logistic regression analysis was employed to identify factors associated with the willingness to use doxy-PEP.
A total of 884 individuals were included in this study. Of these, 53.5% reported a willingness to use doxy-PEP for the prevention of STIs. The main concerns for those unwilling to use doxy-PEP were related to its efficacy (82.5%) and safety (81.7%). Multivariable logistic regression indicated that participants were more likely to express willingness to use doxy-PEP if they had female sexual partners in the past 6 months (adjusted Odds Ratio (aOR): 1.58, 95% CI: 1.11-2.25), had prior or current doxy-PEP use (aOR = 2.39, 95% CI: 1.13-5.05), or had peers currently using doxy-PEP (aOR = 1.58, 95% CI: 1.09-2.30).
The willingness to use doxy-PEP among MSM in South China is relatively low. These findings highlight the need for effective educational and targeted intervention strategies to raise awareness and knowledge toward using doxy-PEP among MSM in China. |
|---|---|
| AbstractList | Doxycycline post-exposure prophylaxis (doxy-PEP) has the potential to decrease the incidence of sexually transmitted infections (STIs) among men who have sex with men (MSM). However, there is a limited literature on willingness to use doxy-PEP among Chinese MSM. This study aimed to examine the willingness to use doxy-PEP and its associated factors among MSM in China. In 2023, we conducted a cross-sectional study in four cities in Guangdong provinces in South China. Data were collected on social-demographic characteristics, sexual behaviors, and the willingness to use doxy-PEP. Multivariable logistic regression analysis was employed to identify factors associated with the willingness to use doxy-PEP. A total of 884 individuals were included in this study. Of these, 53.5% reported a willingness to use doxy-PEP for the prevention of STIs. The main concerns for those unwilling to use doxy-PEP were related to its efficacy (82.5%) and safety (81.7%). Multivariable logistic regression indicated that participants were more likely to express willingness to use doxy-PEP if they had female sexual partners in the past 6 months (adjusted Odds Ratio (aOR): 1.58, 95% CI: 1.11-2.25), had prior or current doxy-PEP use (aOR = 2.39, 95% CI: 1.13-5.05), or had peers currently using doxy-PEP (aOR = 1.58, 95% CI: 1.09-2.30). The willingness to use doxy-PEP among MSM in South China is relatively low. These findings highlight the need for effective educational and targeted intervention strategies to raise awareness and knowledge toward using doxy-PEP among MSM in China. Doxycycline post-exposure prophylaxis (doxy-PEP) has the potential to decrease the incidence of sexually transmitted infections (STIs) among men who have sex with men (MSM). However, there is a limited literature on willingness to use doxy-PEP among Chinese MSM. This study aimed to examine the willingness to use doxy-PEP and its associated factors among MSM in China.BACKGROUNDDoxycycline post-exposure prophylaxis (doxy-PEP) has the potential to decrease the incidence of sexually transmitted infections (STIs) among men who have sex with men (MSM). However, there is a limited literature on willingness to use doxy-PEP among Chinese MSM. This study aimed to examine the willingness to use doxy-PEP and its associated factors among MSM in China.In 2023, we conducted a cross-sectional study in four cities in Guangdong provinces in South China. Data were collected on social-demographic characteristics, sexual behaviors, and the willingness to use doxy-PEP. Multivariable logistic regression analysis was employed to identify factors associated with the willingness to use doxy-PEP.METHODSIn 2023, we conducted a cross-sectional study in four cities in Guangdong provinces in South China. Data were collected on social-demographic characteristics, sexual behaviors, and the willingness to use doxy-PEP. Multivariable logistic regression analysis was employed to identify factors associated with the willingness to use doxy-PEP.A total of 884 individuals were included in this study. Of these, 53.5% reported a willingness to use doxy-PEP for the prevention of STIs. The main concerns for those unwilling to use doxy-PEP were related to its efficacy (82.5%) and safety (81.7%). Multivariable logistic regression indicated that participants were more likely to express willingness to use doxy-PEP if they had female sexual partners in the past 6 months (adjusted Odds Ratio (aOR): 1.58, 95% CI: 1.11-2.25), had prior or current doxy-PEP use (aOR = 2.39, 95% CI: 1.13-5.05), or had peers currently using doxy-PEP (aOR = 1.58, 95% CI: 1.09-2.30).RESULTSA total of 884 individuals were included in this study. Of these, 53.5% reported a willingness to use doxy-PEP for the prevention of STIs. The main concerns for those unwilling to use doxy-PEP were related to its efficacy (82.5%) and safety (81.7%). Multivariable logistic regression indicated that participants were more likely to express willingness to use doxy-PEP if they had female sexual partners in the past 6 months (adjusted Odds Ratio (aOR): 1.58, 95% CI: 1.11-2.25), had prior or current doxy-PEP use (aOR = 2.39, 95% CI: 1.13-5.05), or had peers currently using doxy-PEP (aOR = 1.58, 95% CI: 1.09-2.30).The willingness to use doxy-PEP among MSM in South China is relatively low. These findings highlight the need for effective educational and targeted intervention strategies to raise awareness and knowledge toward using doxy-PEP among MSM in China.CONCLUSIONSThe willingness to use doxy-PEP among MSM in South China is relatively low. These findings highlight the need for effective educational and targeted intervention strategies to raise awareness and knowledge toward using doxy-PEP among MSM in China. Background Doxycycline post-exposure prophylaxis (doxy-PEP) has the potential to decrease the incidence of sexually transmitted infections (STIs) among men who have sex with men (MSM). However, there is a limited literature on willingness to use doxy-PEP among Chinese MSM. This study aimed to examine the willingness to use doxy-PEP and its associated factors among MSM in China. Methods In 2023, we conducted a cross-sectional study in four cities in Guangdong provinces in South China. Data were collected on social-demographic characteristics, sexual behaviors, and the willingness to use doxy-PEP. Multivariable logistic regression analysis was employed to identify factors associated with the willingness to use doxy-PEP. Results A total of 884 individuals were included in this study. Of these, 53.5% reported a willingness to use doxy-PEP for the prevention of STIs. The main concerns for those unwilling to use doxy-PEP were related to its efficacy (82.5%) and safety (81.7%). Multivariable logistic regression indicated that participants were more likely to express willingness to use doxy-PEP if they had female sexual partners in the past 6 months (adjusted Odds Ratio (aOR): 1.58, 95% CI: 1.11-2.25), had prior or current doxy-PEP use (aOR = 2.39, 95% CI: 1.13-5.05), or had peers currently using doxy-PEP (aOR = 1.58, 95% CI: 1.09-2.30). Conclusions The willingness to use doxy-PEP among MSM in South China is relatively low. These findings highlight the need for effective educational and targeted intervention strategies to raise awareness and knowledge toward using doxy-PEP among MSM in China. Keywords: Men who have sex with men, Doxycycline, Prophylaxis, Doxy-PEP, Sexually transmitted infections, China Doxycycline post-exposure prophylaxis (doxy-PEP) has the potential to decrease the incidence of sexually transmitted infections (STIs) among men who have sex with men (MSM). However, there is a limited literature on willingness to use doxy-PEP among Chinese MSM. This study aimed to examine the willingness to use doxy-PEP and its associated factors among MSM in China. In 2023, we conducted a cross-sectional study in four cities in Guangdong provinces in South China. Data were collected on social-demographic characteristics, sexual behaviors, and the willingness to use doxy-PEP. Multivariable logistic regression analysis was employed to identify factors associated with the willingness to use doxy-PEP. A total of 884 individuals were included in this study. Of these, 53.5% reported a willingness to use doxy-PEP for the prevention of STIs. The main concerns for those unwilling to use doxy-PEP were related to its efficacy (82.5%) and safety (81.7%). Multivariable logistic regression indicated that participants were more likely to express willingness to use doxy-PEP if they had female sexual partners in the past 6 months (adjusted Odds Ratio (aOR): 1.58, 95% CI: 1.11-2.25), had prior or current doxy-PEP use (aOR = 2.39, 95% CI: 1.13-5.05), or had peers currently using doxy-PEP (aOR = 1.58, 95% CI: 1.09-2.30). The willingness to use doxy-PEP among MSM in South China is relatively low. These findings highlight the need for effective educational and targeted intervention strategies to raise awareness and knowledge toward using doxy-PEP among MSM in China. Abstract Background Doxycycline post-exposure prophylaxis (doxy-PEP) has the potential to decrease the incidence of sexually transmitted infections (STIs) among men who have sex with men (MSM). However, there is a limited literature on willingness to use doxy-PEP among Chinese MSM. This study aimed to examine the willingness to use doxy-PEP and its associated factors among MSM in China. Methods In 2023, we conducted a cross-sectional study in four cities in Guangdong provinces in South China. Data were collected on social-demographic characteristics, sexual behaviors, and the willingness to use doxy-PEP. Multivariable logistic regression analysis was employed to identify factors associated with the willingness to use doxy-PEP. Results A total of 884 individuals were included in this study. Of these, 53.5% reported a willingness to use doxy-PEP for the prevention of STIs. The main concerns for those unwilling to use doxy-PEP were related to its efficacy (82.5%) and safety (81.7%). Multivariable logistic regression indicated that participants were more likely to express willingness to use doxy-PEP if they had female sexual partners in the past 6 months (adjusted Odds Ratio (aOR): 1.58, 95% CI: 1.11–2.25), had prior or current doxy-PEP use (aOR = 2.39, 95% CI: 1.13–5.05), or had peers currently using doxy-PEP (aOR = 1.58, 95% CI: 1.09–2.30). Conclusions The willingness to use doxy-PEP among MSM in South China is relatively low. These findings highlight the need for effective educational and targeted intervention strategies to raise awareness and knowledge toward using doxy-PEP among MSM in China. BackgroundDoxycycline post-exposure prophylaxis (doxy-PEP) has the potential to decrease the incidence of sexually transmitted infections (STIs) among men who have sex with men (MSM). However, there is a limited literature on willingness to use doxy-PEP among Chinese MSM. This study aimed to examine the willingness to use doxy-PEP and its associated factors among MSM in China.MethodsIn 2023, we conducted a cross-sectional study in four cities in Guangdong provinces in South China. Data were collected on social-demographic characteristics, sexual behaviors, and the willingness to use doxy-PEP. Multivariable logistic regression analysis was employed to identify factors associated with the willingness to use doxy-PEP.ResultsA total of 884 individuals were included in this study. Of these, 53.5% reported a willingness to use doxy-PEP for the prevention of STIs. The main concerns for those unwilling to use doxy-PEP were related to its efficacy (82.5%) and safety (81.7%). Multivariable logistic regression indicated that participants were more likely to express willingness to use doxy-PEP if they had female sexual partners in the past 6 months (adjusted Odds Ratio (aOR): 1.58, 95% CI: 1.11–2.25), had prior or current doxy-PEP use (aOR = 2.39, 95% CI: 1.13–5.05), or had peers currently using doxy-PEP (aOR = 1.58, 95% CI: 1.09–2.30).ConclusionsThe willingness to use doxy-PEP among MSM in South China is relatively low. These findings highlight the need for effective educational and targeted intervention strategies to raise awareness and knowledge toward using doxy-PEP among MSM in China. |
| ArticleNumber | 911 |
| Audience | Academic |
| Author | Huang, Shujie Wang, Cheng Zhao, Peizhen Liang, Peng |
| Author_xml | – sequence: 1 givenname: Peng surname: Liang fullname: Liang, Peng – sequence: 2 givenname: Peizhen surname: Zhao fullname: Zhao, Peizhen – sequence: 3 givenname: Shujie surname: Huang fullname: Huang, Shujie – sequence: 4 givenname: Cheng surname: Wang fullname: Wang, Cheng |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40646493$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkstu1DAUhiNURC_wAiyQJTawSIkdx4nZVcNtpEqVKJel5TgnE48Se2o7beaJeE2cmVIYxAJZ8uX4O__Rsf_T5MhYA0nyHGfnGFfsjcekKnmakSLFmPAsnR4lJ5iWOCV5To_-2B8np96vswyXFeFPkmOaMcooz0-SH99132uzMuA9ChZJpWAT0Ds7bdVWxRtAG-tDClNcRhdPzm66bS8n7VFrHaqlCuC07JEPMbRxcAsmaGuQHKxZoQEMuuss6uQtIA8TutOh20W1Qdd2DB04gxadNvItkkg5633qQc0SUVTGaeu1f5o8bmXv4dn9epZ8_fD-y-JTenn1cbm4uExVQXhIq7rBShVVpRjIlrayJKxuVNZyqMuyqDnL8woXddPwXHJKa942GeclaQlmwEl-liz3uo2Va7FxepBuK6zUYhewbiWkC1r1ICip50JU4VhJqrLKGOFMYVzzrOEUR61Xe634Zjcj-CAG7RX0vTRgRy9yEnlSlGwu-_IvdG1HF3ufqZxxXpAi_02tZKyvTWuDk2oWFRcVLWnBCl5E6vwfVBwNDFpFC7U6xg8SXh8kRCbAFFZy9F4srz__P3v17ZB9cd_UWA_QPLzmL_dFgOyB3a87aB8QnInZ4mJvcREtLnYWF1P-Ez_Q7eU |
| Cites_doi | 10.1016/j.puhe.2023.06.010 10.1016/S1473-3099(17)30725-9 10.1186/s12889-022-14323-1 10.15585/mmwr.rr7302a1 10.1016/j.ypmed.2024.107977 10.1097/OLQ.0000000000001395 10.1002/jia2.25389 10.1186/s12889-024-19987-5 10.1071/SH23011 10.1097/OLQ.0000000000001130 10.1186/s12889-019-7730-0 10.1097/OLQ.0000000000001996 10.1016/j.lanwpc.2021.100143 10.1007/s11904-013-0194-4 10.7189/jogh.14.04004 10.1186/1741-7015-9-111 10.1097/OLQ.0000000000002061 10.3389/fmed.2021.781759 10.1136/sextrans-2020-054592 10.1016/S2352-3018(19)30043-8 10.1056/NEJMoa2304007 10.1016/S2352-3018(20)30307-6 10.1186/s12889-022-14211-8 10.1371/journal.pone.0269780 10.1111/hiv.13542 10.1056/NEJMoa2211934 10.1002/jia2.26342 10.1071/SH18060 10.1186/s12889-024-18804-3 10.1016/j.ijid.2024.107186 10.1136/bmjopen-2019-031578 10.1186/s12879-022-07966-3 10.1007/s10508-022-02507-0 10.1016/S1473-3099(20)30172-9 10.1016/j.jinf.2021.12.045 10.1371/journal.pmed.1003928 10.2196/37936 |
| ContentType | Journal Article |
| Copyright | 2025. The Author(s). COPYRIGHT 2025 BioMed Central Ltd. 2025. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: 2025. The Author(s). – notice: COPYRIGHT 2025 BioMed Central Ltd. – notice: 2025. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM IOV ISR 3V. 7QL 7T2 7U9 7X7 7XB 88E 8C1 8FI 8FJ 8FK ABUWG AEUYN AFKRA AZQEC BENPR C1K CCPQU DWQXO FYUFA GHDGH H94 K9. M0S M1P M7N PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 DOA |
| DOI | 10.1186/s12879-025-11290-x |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Opposing Viewpoints Gale In Context: Science ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Health and Safety Science Abstracts (Full archive) Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Public Health Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Proquest Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Environmental Sciences and Pollution Management ProQuest Central ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Health & Medical Research Collection AIDS and Cancer Research Abstracts Health & Safety Science Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health Virology and AIDS Abstracts ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Education Public Health |
| EISSN | 1471-2334 |
| EndPage | 10 |
| ExternalDocumentID | oai_doaj_org_article_42b588c4c1af4ac7806296c11b90d941 A847456595 40646493 10_1186_s12879_025_11290_x |
| Genre | Journal Article |
| GeographicLocations | China United States--US |
| GeographicLocations_xml | – name: China – name: United States--US |
| GrantInformation_xml | – fundername: The Science and Technology Projects in Guangzhou grantid: 2024A04J4485 – fundername: Natural Science Foundation of Guangdong Province of China grantid: 2022A1515-011454 – fundername: World Health Organization-e-TDR grantid: 2024/1446181-0 |
| GroupedDBID | --- 0R~ 23N 2WC 53G 5VS 6J9 6PF 7X7 88E 8C1 8FI 8FJ AAFWJ AAJSJ AASML AAWTL AAYXX ABDBF ABUWG ACGFO ACGFS ACIHN ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR IOV ISR ITC KQ8 M1P M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS UKHRP W2D WOQ WOW XSB CGR CUY CVF ECM EIF NPM 3V. 7QL 7T2 7U9 7XB 8FK AZQEC C1K DWQXO H94 K9. M48 M7N PKEHL PQEST PQUKI 7X8 PUEGO |
| ID | FETCH-LOGICAL-c529t-8bd1cc588c6eaf4fa726bdc0f9eb775b9633815bdd93a944b9fd09972f216e923 |
| IEDL.DBID | DOA |
| ISSN | 1471-2334 |
| IngestDate | Wed Aug 27 01:31:27 EDT 2025 Sun Jul 13 18:30:54 EDT 2025 Wed Aug 06 19:07:30 EDT 2025 Wed Jul 16 16:54:25 EDT 2025 Tue Jul 15 03:52:36 EDT 2025 Tue Jul 15 03:21:00 EDT 2025 Tue Jul 15 03:20:45 EDT 2025 Tue Jul 15 01:30:41 EDT 2025 Tue Aug 05 12:02:04 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Doxy-PEP China Doxycycline Men who have sex with men Prophylaxis Sexually transmitted infections |
| Language | English |
| License | 2025. The Author(s). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c529t-8bd1cc588c6eaf4fa726bdc0f9eb775b9633815bdd93a944b9fd09972f216e923 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | https://doaj.org/article/42b588c4c1af4ac7806296c11b90d941 |
| PMID | 40646493 |
| PQID | 3236995253 |
| PQPubID | 42582 |
| PageCount | 10 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_42b588c4c1af4ac7806296c11b90d941 proquest_miscellaneous_3229625762 proquest_journals_3236995253 gale_infotracmisc_A847456595 gale_infotracacademiconefile_A847456595 gale_incontextgauss_ISR_A847456595 gale_incontextgauss_IOV_A847456595 pubmed_primary_40646493 crossref_primary_10_1186_s12879_025_11290_x |
| PublicationCentury | 2000 |
| PublicationDate | 2025-07-11 |
| PublicationDateYYYYMMDD | 2025-07-11 |
| PublicationDate_xml | – month: 07 year: 2025 text: 2025-07-11 day: 11 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: London |
| PublicationTitle | BMC infectious diseases |
| PublicationTitleAlternate | BMC Infect Dis |
| PublicationYear | 2025 |
| Publisher | BioMed Central Ltd BioMed Central BMC |
| Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
| References | 11290_CR14 11290_CR18 W Xu (11290_CR7) 2024; 24 A Liu (11290_CR12) 2024 A Eubanks (11290_CR30) 2022; 22 11290_CR31 LH Bachmann (11290_CR11) 2024; 73 11290_CR32 L Fusca (11290_CR20) 2020; 47 S Hu (11290_CR35) 2024; 27 Y Zhang (11290_CR8) 2019; 19 X-S Chen (11290_CR5) 2011; 9 F Yang (11290_CR6) 2020; 20 VJ Cornelisse (11290_CR24) 2023; 20 MW Traeger (11290_CR26) 2024 EPF Chow (11290_CR1) 2019; 6 W-J Lu (11290_CR4) 2023; 221 AF Luetkemeyer (11290_CR10) 2023; 388 J Stewart (11290_CR27) 2023; 389 H Jian (11290_CR3) 2024; 24 X Zhang (11290_CR13) 2022; 22 11290_CR25 C O’Halloran (11290_CR19) 2021; 97 YA Amirkhanian (11290_CR36) 2014; 11 Y Zhou (11290_CR37) 2022; 19 11290_CR40 Z Liu (11290_CR34) 2022; 84 Y Zheng (11290_CR2) 2024; 14 B Lin (11290_CR29) 2022; 22 11290_CR23 C Wang (11290_CR16) 2019; 9 HM Zimmermann (11290_CR28) 2019; 22 JE Haberer (11290_CR33) 2021; 8 Y Wang (11290_CR38) 2023; 52 MK Smith (11290_CR15) 2021; 11 J-M Molina (11290_CR9) 2018; 18 L-G Yang (11290_CR17) 2018 JJ Park (11290_CR21) 2021; 48 LG Johnston (11290_CR39) 2022; 17 R Ehsan (11290_CR22) 2024; 183 |
| References_xml | – volume-title: Gonorrhea and chlamydia prevalence in different anatomical sites among men who have sex with men year: 2018 ident: 11290_CR17 – volume: 221 start-page: 106 year: 2023 ident: 11290_CR4 publication-title: Public Health doi: 10.1016/j.puhe.2023.06.010 – volume: 18 start-page: 308 year: 2018 ident: 11290_CR9 publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(17)30725-9 – volume: 22 start-page: 1926 year: 2022 ident: 11290_CR13 publication-title: BMC Public Health doi: 10.1186/s12889-022-14323-1 – volume: 73 start-page: 1 year: 2024 ident: 11290_CR11 publication-title: MMWR Recomm Rep doi: 10.15585/mmwr.rr7302a1 – volume: 183 start-page: 107977 year: 2024 ident: 11290_CR22 publication-title: Prev Med doi: 10.1016/j.ypmed.2024.107977 – volume: 48 start-page: 615 year: 2021 ident: 11290_CR21 publication-title: Sex Trans Dis doi: 10.1097/OLQ.0000000000001395 – volume: 22 start-page: e25389 year: 2019 ident: 11290_CR28 publication-title: J Intern AIDS Soc doi: 10.1002/jia2.25389 – ident: 11290_CR18 doi: 10.1186/s12889-024-19987-5 – volume: 20 start-page: 99 year: 2023 ident: 11290_CR24 publication-title: Sex Health doi: 10.1071/SH23011 – volume: 47 start-page: 224 year: 2020 ident: 11290_CR20 publication-title: Sex Trans Dis doi: 10.1097/OLQ.0000000000001130 – volume: 19 start-page: 1314 year: 2019 ident: 11290_CR8 publication-title: BMC Public Health doi: 10.1186/s12889-019-7730-0 – year: 2024 ident: 11290_CR12 publication-title: Sex Trans Dis doi: 10.1097/OLQ.0000000000001996 – volume: 11 start-page: 100143 year: 2021 ident: 11290_CR15 publication-title: Lancet Reg Health - Western Pac doi: 10.1016/j.lanwpc.2021.100143 – volume: 11 start-page: 81 year: 2014 ident: 11290_CR36 publication-title: Curr HIV/AIDS Rep doi: 10.1007/s11904-013-0194-4 – volume: 14 start-page: 04004 year: 2024 ident: 11290_CR2 publication-title: J Glob Health doi: 10.7189/jogh.14.04004 – volume: 9 start-page: 111 year: 2011 ident: 11290_CR5 publication-title: BMC Med doi: 10.1186/1741-7015-9-111 – volume: 24 start-page: 2484 year: 2024 ident: 11290_CR7 publication-title: BMC Public Health doi: 10.1186/s12889-024-19987-5 – year: 2024 ident: 11290_CR26 publication-title: Sex Trans Dis doi: 10.1097/OLQ.0000000000002061 – ident: 11290_CR14 doi: 10.3389/fmed.2021.781759 – volume: 97 start-page: 429 year: 2021 ident: 11290_CR19 publication-title: Sex Transm Infect doi: 10.1136/sextrans-2020-054592 – volume: 6 start-page: e396 year: 2019 ident: 11290_CR1 publication-title: Lancet HIV doi: 10.1016/S2352-3018(19)30043-8 – volume: 389 start-page: 2331 year: 2023 ident: 11290_CR27 publication-title: N Engl J Med doi: 10.1056/NEJMoa2304007 – volume: 8 start-page: e130 year: 2021 ident: 11290_CR33 publication-title: Lancet HIV doi: 10.1016/S2352-3018(20)30307-6 – volume: 22 start-page: 1832 year: 2022 ident: 11290_CR30 publication-title: BMC Public Health doi: 10.1186/s12889-022-14211-8 – volume: 17 start-page: e0269780 year: 2022 ident: 11290_CR39 publication-title: PLoS ONE doi: 10.1371/journal.pone.0269780 – ident: 11290_CR25 doi: 10.1111/hiv.13542 – volume: 388 start-page: 1296 year: 2023 ident: 11290_CR10 publication-title: N Engl J Med doi: 10.1056/NEJMoa2211934 – volume: 27 start-page: e26342 year: 2024 ident: 11290_CR35 publication-title: J Int AIDS Soc doi: 10.1002/jia2.26342 – ident: 11290_CR31 doi: 10.1071/SH18060 – volume: 24 start-page: 1579 year: 2024 ident: 11290_CR3 publication-title: BMC Public Health doi: 10.1186/s12889-024-18804-3 – ident: 11290_CR23 doi: 10.1016/j.ijid.2024.107186 – volume: 9 start-page: e031578 year: 2019 ident: 11290_CR16 publication-title: BMJ Open doi: 10.1136/bmjopen-2019-031578 – volume: 22 start-page: 969 year: 2022 ident: 11290_CR29 publication-title: BMC Infect Dis doi: 10.1186/s12879-022-07966-3 – ident: 11290_CR40 – volume: 52 start-page: 2025 year: 2023 ident: 11290_CR38 publication-title: Arch Sex Behav doi: 10.1007/s10508-022-02507-0 – volume: 20 start-page: 976 year: 2020 ident: 11290_CR6 publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(20)30172-9 – volume: 84 start-page: 248 year: 2022 ident: 11290_CR34 publication-title: J Infect doi: 10.1016/j.jinf.2021.12.045 – volume: 19 start-page: e1003928 year: 2022 ident: 11290_CR37 publication-title: PLoS Med doi: 10.1371/journal.pmed.1003928 – ident: 11290_CR32 doi: 10.2196/37936 |
| SSID | ssj0017829 |
| Score | 2.4269722 |
| Snippet | Doxycycline post-exposure prophylaxis (doxy-PEP) has the potential to decrease the incidence of sexually transmitted infections (STIs) among men who have sex... Background Doxycycline post-exposure prophylaxis (doxy-PEP) has the potential to decrease the incidence of sexually transmitted infections (STIs) among men who... BackgroundDoxycycline post-exposure prophylaxis (doxy-PEP) has the potential to decrease the incidence of sexually transmitted infections (STIs) among men who... Abstract Background Doxycycline post-exposure prophylaxis (doxy-PEP) has the potential to decrease the incidence of sexually transmitted infections (STIs)... |
| SourceID | doaj proquest gale pubmed crossref |
| SourceType | Open Website Aggregation Database Index Database |
| StartPage | 911 |
| SubjectTerms | Adolescent Adult Anti-Bacterial Agents - administration & dosage Anti-Bacterial Agents - therapeutic use China China - epidemiology Chlamydia Condoms Cross-Sectional Studies Disease prevention Doxy-PEP Doxycycline Doxycycline - administration & dosage Doxycycline - therapeutic use Drug resistance Education Effectiveness Ethnicity Gonorrhea Health aspects Health attitudes HIV Homosexuality, Male - psychology Human immunodeficiency virus Humans Male Males Marital status Men Men who have sex with men Middle Aged MSM (Men who have sex with men) Patient Acceptance of Health Care - statistics & numerical data Post-Exposure Prophylaxis Prevention Prophylaxis Psychological aspects Public health Questionnaires Regression analysis Sexual Behavior Sexual Partners Sexually transmitted diseases Sexually Transmitted Diseases - prevention & control Sexually Transmitted Diseases, Bacterial - prevention & control Sexually transmitted infections Social behavior Social networks Sociodemographics STD Surveys Syphilis Urine Young Adult |
| SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ti9QwEA56gggiuupZPSWK4Acp16TpS_wi58txCqegnuy3kKTp3oG2a9vV3i_ybzqTZldW0U_LNtPdJpOZPJlOniHkcV1b7XSqkbeVx6JiaQyoOos1dyYxJWBsT2B6_C4_OhFv59k8BNz6kFa59oneUVetxRj5fsrTHG7kWfp8-S3GqlH4djWU0LhILiF1Gc7qYr7ZcDFY_eT6oEyZ7_fgiwsZYwFXRBlJPG4tRp6z_2_P_Afe9OvO4XVyLQBGejBp-Aa54JoZ1loOeRkzcvk4vB6fkatTEI5OZ4tukp8-mtIs0J3RoaXaYhILfdWO5_Ycz0Q6umz7IXYjfKw6-Na1MOxf9HjWU0Cz1ExczvD_4Al6aHYhPZL6IkX0q2voj9OWnurvjvZupBjW9VfPGuqr87muob5G9zOqqR-FuPfZX9gpHRhRbpGTw9efXh7FoTJDbDMuh7g0FbM2K0ubO12LWhc8N5VNaulMUWQGrBqQQGaqSqZaCmFkXfkjujVnuQNMeZvsNG3j7hBas8RkUvAic4WQOTOmTKrS1dpWOk3TKiJP1ypSy4mAQ_mNS5mrSaEKFKq8QtUYkReoxY0kkmf7C223UMEWleAGH11YBs-ubVEmOZe5ZczIpJKCReQRzgGF9BgN5t8s9Krv1Zv3n9UBLOaIgWX2L6GPH7aEngShuh06bXU48wBdR9qtLcm9LUkwcrvdvJ6PKjiZXv02iYg83DTjnZg417h2hTLQNdxU8ojsTvN4MziA5UQuZHr3_z9-j1zhaDPIJsr2yM7Qrdx9QGKDeeDN7RcTGjNY priority: 102 providerName: ProQuest |
| Title | Willingness to accept Doxycycline post-exposure prophylaxis for bacterial stis prevention among men who have sex with men in Southern China: a cross-sectional analysis |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/40646493 https://www.proquest.com/docview/3236995253 https://www.proquest.com/docview/3229625762 https://doaj.org/article/42b588c4c1af4ac7806296c11b90d941 |
| Volume | 25 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELagSIgL4k2grAxC4oCiJo7jxNy6pVVBakELRSsulu04bSVIqiQL6S_ibzLjZFcEhLhwySrxRBvPwzNOZr4h5HlZWu10ohG3lYW8iJMQouo01MyZyOQQY3sA06NjcXjC3y7T5S-tvjAnbIAHHhi3w5lJ89xyG-uSa5vlkWBS2Dg2MiqkL1ln4PPWm6nx-wH4PbkukcnFTgurcCZDbN2K8UUU9hM35NH6_1yTf4s0vcc5uEVujqEi3R0e8Ta54qo75PrR-DH8Lvnh35VUp7hY0a6m2mKKCn1d95f2EiseHb2o2y50PfysGjhramDqF92ftxRiVWoGpGb4D7DzFobdmPxIfQsi-tVV9PtZTc_0N0db11N8aeuvnlfU995zTUV9B-5XVFM_07D1uV344HrEO7lHTg72P-4dhmPfhdCmTHZhborYWuS6cMD0UmdMmMJGpXQmy1IDNgt-PjVFIRMtOTeyLHwBbsli4SBivE-2qrpyDwkt48ikkrMsdRmXIjYmj4rcldoWOkmSIiAv12JQFwO8hvLbklyoQWgKhKa80FQfkDlKakOJ0Nj-AiiMGhVG_UthAvIM5awQ_KLC7JpTvWpb9ebdJ7ULrhojXJn-jejDYkL0YiQq667RVo8VDTB1BNWaUG5PKMGE7XR4rXNqXEJalbBEgKWwNAnI080w3olpcZWrV0gDU8MtIwvIg0FXN8yBSI0LLpNH_4Npj8kNhtaDiKLxNtnqmpV7AtFYZ2bkarbM4JjvxTNybb5__H4x88YIx8X880_YkjbM |
| linkProvider | Directory of Open Access Journals |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLamIQESQlBuhQEGgXhA0RLHuRgJobExtWwdEmzT3oztON0kSErSsvYX8cZv5BwnKSoI3vYUNT5J45zbZ-dcCHmW50ZZFSqs28o8ngWhB6g68hSz2tcpYGxXwHR0EA-O-PuT6GSN_OxyYTCssrOJzlBnpcE98s2QhTFcyKLwzeSbh12j8Otq10KjEYs9uziHJVv9ergD_H3O2O67w-2B13YV8EzExNRLdRYYE6Wpia3Kea4SFuvM-LmwOkkiDRIJXizSWSZCJTjXIs9cemnOgtgKLHQAJv8SD0E1MTN9exlSEoC3FV1iThpv1mD7E-Fhw1hENb43X3F-rkfA357gD3zr_NzuDXK9Bah0q5Gom2TNFj3s7dzGgfTI5VH7Ob5HrjWbfrTJZbpFfrjdm2KM5pNOS6oMBs3QnXK-MAvMwbR0UtZTz87hMKvgV1UCm7-o-VlNAT1T3dSOhv8Hy1PDsG3DMalrikS_2oKen5b0VH23tLZzitvI7uxZQV03QFsV1PUEf0UVdW_Bq120GU5KtRVYbpOjC-HZHbJelIW9R2ge-DoSnCWRTbiIA61TP0ttrkymwjDM-uRlxyI5aQp-SLdQSmPZMFQCQ6VjqJz3yVvk4pISi3W7E2U1lq3uS840Pjo3ATy7Mknqx0zEJgi08DPBgz55ijIgsRxHgfE-YzWrazn8cCy3ADwg5hbRv4g-fVwhetES5eW0Uka1ORYwdSzztUK5sUIJRsWsDnfyKFujVsvfKtgnT5bDeCUG6hW2nCENTA0XsaxP7jZyvHw5gB15zEV4__83f0yuDA5H-3J_eLD3gFxlqD9YyTTYIOvTamYfAgqc6kdO9Sj5fNG6_guof3DX |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Willingness+to+accept+Doxycycline+post-exposure+prophylaxis+for+bacterial+stis+prevention+among+men+who+have+sex+with+men+in+Southern+China%3A+a+cross-sectional+analysis&rft.jtitle=BMC+infectious+diseases&rft.au=Peng+Liang&rft.au=Peizhen+Zhao&rft.au=Shujie+Huang&rft.au=Cheng+Wang&rft.date=2025-07-11&rft.pub=BMC&rft.eissn=1471-2334&rft.volume=25&rft.issue=1&rft.spage=1&rft.epage=10&rft_id=info:doi/10.1186%2Fs12879-025-11290-x&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_42b588c4c1af4ac7806296c11b90d941 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2334&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2334&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2334&client=summon |